CD8A and neoplasm: Importantly, clinical and experimental observations suggest that the presence of IFN-γ cytokines, tumor infiltrating CD8 T cells, and PD-L1+ immune cells within the TME is likely an indication of pre-existing antitumor immune responses and is potentially more responsive to therapeutic interventions (Hegde et al., 2016).